返回 Agenda
Session Chair(s)
Yuan Li
Director, Project Management
MSD R&D (China) Co., Ltd., China
Speaker(s)
Overview of Project Management in Drug Development
Timothy M. Phelan, PHD
Merck & Co., Inc., United States
Executive Director
Value Added Project Leadership in New Drug Development, Opportunity and Challenge
Maxwell Kirkby
IRESSA , AstraZeneca, China
Global Product Vice President
Clara Gu
Bayer, China
TA Head Medical Affairs
Michael Jiang
Lilly Suzhou pharmaceutical Co., Ltd., China
COO
Kumar Penmetsa
BristolMyers Squibb, China
Senior Director